EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

152 hedge funds and large institutions have $328M invested in Eagle Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 19 closing their positions.

Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
59
Reduced
48
Closed
19
Calls
$1.78M
Puts
$15K
Net Calls
+$1.77M
Net Calls Change
-$1.83M
Name Market Value Shares Shares
Change
Shares
Change %
EI
151
Ellevest Inc
New York
$409 14 +14 New
FMII
152
Farmers & Merchants Investments Inc
Nebraska
$205 7
Man Group
153
Man Group
United Kingdom
-68,686 Closed
Pacer Advisors
154
Pacer Advisors
Pennsylvania
-59,189 Closed
SGI
155
Summit Global Investments
Utah
-34,325 Closed
HIM
156
Hillsdale Investment Management
Ontario, Canada
-33,665 Closed
GCP
157
GSA Capital Partners
United Kingdom
-23,137 Closed
PAM
158
Panagora Asset Management
Massachusetts
-11,012 Closed
PI
159
Putnam Investments
Massachusetts
-10,984 Closed
SG Americas Securities
160
SG Americas Securities
New York
-9,133 Closed
YCM
161
Yousif Capital Management
Michigan
-8,522 Closed
Ensign Peak Advisors
162
Ensign Peak Advisors
Utah
-7,577 Closed
MOACM
163
Mutual of America Capital Management
New York
-2,115 Closed
QT
164
Quantbot Technologies
New York
-1,700 Closed
SOW
165
State of Wyoming
Wyoming
-516 Closed
MAM
166
Meeder Asset Management
Ohio
-70 Closed
FRA
167
Front Row Advisors
California
-40 Closed
SWM
168
Selective Wealth Management
Virginia
-15 Closed
IA
169
IFP Advisors
Florida
-14 Closed
BTI
170
Blue Trust Inc
Georgia
-7 Closed
AF
171
Allworth Financial
California
-6 Closed
CFGS
172
Concourse Financial Group Securities
Alabama
Macquarie Group
173
Macquarie Group
Australia
VCM
174
Versant Capital Management
Arizona
HT
175
HAP Trading
New York